Romero-Gomez, M. Et Al. 2023. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease. JOURNAL OF HEPATOLOGY , vol.79, no.4 , 888-897.

Romero-Gomez, M., Lawitz, E., Shankar, R. R., Chaudhri, E., Liu, J., Lam, R. L. H., ... Kaufman, K. D.(2023). A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease. JOURNAL OF HEPATOLOGY , vol.79, no.4, 888-897.

Romero-Gomez, Filiz Et Al. "A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease," JOURNAL OF HEPATOLOGY , vol.79, no.4, 888-897, 2023

Romero-Gomez, Filiz Et Al. "A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease." JOURNAL OF HEPATOLOGY , vol.79, no.4, pp.888-897, 2023

Romero-Gomez, M. Et Al. (2023) . "A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease." JOURNAL OF HEPATOLOGY , vol.79, no.4, pp.888-897.

@article{article, author={Filiz AKYÜZ Et Al. }, title={A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease}, journal={JOURNAL OF HEPATOLOGY}, year=2023, pages={888-897} }